The cambridge peanut allergy clinic: Real world safety and efficacy outcomes during oral immunotherapy with characterised peanut flour

被引：0
|
作者：
Clark, A. [1 ]
Zolkipli, Q. [1 ]
Ewan, P. [1 ]
机构：
[1] Cambridge Univ Hosp, Cambridge, England
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
OA0022
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [31] Peanut Oral Immunotherapy: Data from a Real-World Clinical Practice
    Wang, Julie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (02): : 427 - 428
  • [32] First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy
    Soller, L.
    Abrams, E. M.
    Carr, S.
    PEDIATRICS, 2021, 148 : S33 - S33
  • [33] Real World Adoption of FDA-approved Peanut Oral Immunotherapy with Palforzia
    Shahzad Mustafa, S.
    Patrawala, Sara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB108 - AB108
  • [34] First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy
    Soller, Lianne
    Abrams, Elissa M.
    Carr, Stuart
    Kapur, Sandeep
    Rex, Gregory A.
    Leo, Sara
    McHenry, Mary
    Vander Leek, Timothy K.
    Yeung, Joanne
    Cook, Victoria E.
    Wong, Tiffany
    Hildebrand, Kyla J.
    Mak, Raymond
    Gerstner, Thomas, V
    Cameron, Scott B.
    Chan, Edmond S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1349 - +
  • [35] First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy
    Soller, Lianne
    Abrams, Elissa
    Carr, Stuart
    Kapur, Sandy
    Rex, Gregory
    Lidman, Per
    Vander Leek, Timothy
    Yeung, Joanne
    McHenry, Mary
    Wong, Tiffany
    Cook, Victoria
    Hildebrand, Kyla
    Gerstner, Thomas
    Mak, Raymond
    Hsu, Elaine
    Cameron, Scott
    Chan, Edmond
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB72 - AB72
  • [36] A CLINICAL TRIAL TO EXAMINE THE SAFETY AND EFFICACY OF PEANUT ORAL IMMUNOTHERAPY AT A COMMUNITY BASED FOOD ALLERGY RESEARCH CENTER.
    Nouman, G.
    Factor, J.
    Mendelson, L.
    Lester, M.
    Lee, J.
    Sproviero, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A14 - A14
  • [37] Efficacy and safety of AR101: results of the phase 3 peanut allergy oral immunotherapy study for desensitization (PALISADE)
    Hourihane, Jonathan O'B
    Vereda, Andrea
    Jones, Stacie
    Burks, A. Wesley
    Zawadzki, Rezi
    Casale, Thomas
    Shreffler, Wayne
    Matthews, John
    McIntosh, Stuart
    Vickery, Brian
    Adelman, Daniel
    Beyer, Kirsten
    du Toit, George
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1529 - 1529
  • [38] Changes in peanut and peanut allergen component immunoglobulin G4 levels over time in children with peanut allergy treated with peanut oral immunotherapy during the palisade trial
    Nilsson, C.
    Vereda, A.
    Borres, M.
    Sodergren, E.
    Rudengren, M.
    Fernandez-Rivas, M.
    ALLERGY, 2023, 78 : 172 - 173
  • [39] Safety and Feasibility of Peanut, Tree Nut, and Sesame Oral Immunotherapy in Infants and Toddlers in a Real-World Setting
    Huang, Jenny
    Puglisi, Leah H.
    Cook, Kevin A.
    Kelso, John M.
    Wangberg, Hannah
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (01):
  • [40] Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy
    Virkud, Yamini V.
    Burks, A. Wesley
    Steele, Pamela H.
    Edwards, Lloyd J.
    Berglund, Jelena P.
    Jones, Stacie M.
    Scurlock, Amy M.
    Perry, Tamara T.
    Pesek, Robert D.
    Vickery, Brian P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (03) : 882 - +
12345